Solent Multiple Sclerosis
Therapies Limited
Flnancial A¢￿￿nts for the Perlod Ended
31 MaTch 2026
Company Registsatlon Number: 2215154

Solent Multiple Sclerosis Therapies Limited
Report and Accounts for the Period Ended 31 March 2026
CONTENTS
PAGES
Report of the Directors
Independent Examinerfs Report
Stslement of Financial Acbvittes
Income and Expendrture Account
Batan¢e Sheet
Notes lo the Acuunts
7-10
The folkhytng pages do not fomi part of statutory accounts.
Summary Income arKI Expendttijre Account
Income Detsil
12
PhyS￿l0Ste0IRefieX1ShIatsU anaty&"s
13
Bank Balances
14
Fixed Assels
15
Detailed Irrtc*rte and ExpendrtUTe Aeeount
16

Solent Multiple Sclerosis Therapies Limited
Accounts for the Period Ended 31 March 2026
Trustee5
R Hayter
- Acting Chaimian
A Alexander
A Sandford
R MooThen
K Ebbens
K Silman
L Rtckman
C Alexander
Registered Office
Bradbury House
56 Hewett Road
North End
Portsmoyth
Hampshire
P02 OQP
Bankers
Lloyds TSB plc
16A High Street
Cosham
Portsmouth
Hampshire
P06 3BY
Company Number
2215154
Accounlanls
Hunter Simmons Ltd
3a London Road
Purbrook
Walerlooville
Hampshire
P07 5LQ

Solent Multiple Sclerosis Therapies Limited
Report of the Directors for the Period Ended 31 March 2026
Report of the Directors
The directors herwth present the aC￿￿nIS for the period ended 31 March 2026.
ActSvfties of the Company
The companls principal aclNty is to aid the condikn.on of those suffering from rnUtt¥)￿ sclerosis
by PiOVKling guidance, practical support and therapy lo those such pe￿ns.
Directors
The directors of the company throUgh￿t the yearwere as frAkM.'
A Sandford
A Alexander
R Moorhen
L Rt¢km8n
R HaY(er
K Silman
L Clarke (Reswned 18.07.25) C thxander
K Ebbens IReswJned 11.01.26)
S Emery (Resoned 02.06.251
The directors do not hokl any shares in Ihe cc¥npany.
Charitable Status
The company is a registered Charty with the Charity c￿misSiOnerS in England and Wales.
Company Number and Charlty Numbel
The company regisler&J number is 2215154 and the Regi8ter&J Charity number is 299545.
Govgrning Document
The goveming document is the MemorandL¢m atMI Articles of Assock4tion.
Trustees
The directors have produ¢ed a DirectOTS' Report as required by Company Law instead of a
Tiuslees, ReporL
Rggi$tered Office
The fegislered office of the ch*ty is Bradbury House. % Hewett Road, North Etxl, Portsmothh,
Hampshire P02 QQP.
Exemptlons
Advantage has been taken in the preparation of the Directors, Rewt of the special exemptions
applicable to small companies conferred by Part 15 of the Companies Act 2006.
y Orde
of the Boar
..R Hayter- Chaifman

Independent Examiner's Report to the Trustees of
Solent Multiple Sclerosis Therapies Limited
I report to the charty trust￿$ on my eXam￿atIOn of the acccHJnts of the Cmipany fof the year
ended 31 M8r¢h 2026.
ResponsibilitTe5 and basis of report
As the Iruslees of the Charty {8nd also its directors for the purposes of ccmxpany lawl
you are responsible for the preparatKJn ol the accounts in accordance with the requirements of the
Companies Act 20(￿ I'the 21K% Acri.
Having satisfied myself that the accounts of the Ci)mpany are nol required lo be audrted under
Part 16 of the 2006 Act are eligible for indepersdent examinatw)rF, I report in respect of my
examination of your charivs accounts as Carried oul under sectton 145 of the Chartties Act 2011
{'Ihe 2011 Act'l. In carryng out my examination I have folkn¥ed the DirectKffls gNen by the Charity
Cornmission under section 145(51 {bl of the 2011 ACL
Indapendent examinerfs statement
I have completed my exarninalion. I confi￿￿ that rKJ rnatteT5 have come to my attention in
connection with the examination giving me cause to beI￿ve..
accounting ￿COrdS We￿ nol kept in re$￿t of the Company as requwed by sect¢on 386 of the
201% A¢( or
the accounts do not accoTd wth those records., or
the accounts do not compty with the accountirwa ￿qu1￿mentS of section 396 of the 2006 Act
other than any reqLfirement that that accounts give a true and fair view which is not a matter
considered as part of an independent exarninat￿n. or
the 8¢counls have not been prepared in accordance with the methcxls and princpks ofthe
Slalemenl of Recommended Prath"ce for accounting and reporting by Charit￿S lapplicable lo
charities preparing their accounts in acwrdanGe wilh the Financial Reporting Stsndard
applicable in the UK and Republi¢ of Ireland IFRS 10211
I have no concems and have come acFOSS no other matters in connection with the examÈnatK)n to which
attention should be drawn in this report in orderto enable a proper understanding ol the accounts lo be
re¥h￿.
Sean Hunter, FFP FIPA
Institute of Financial Accountants
Membership Number". 232174
Hunter Simmons Ltd
3a London Road
Purbrook
Waterlcoville
Hampshire
P07 5LQ
If MA1 2L7LL

Solent Multiple Sclerosis Therapies Limited
ststement of Financial Activities
For the Period Ended 31 MarGh 2026
Notes
Mar-26
Mar-25
General Fund
Incomlng Resources:
Don81ions'.
Donalions and Grfts
132.5(
155.102
Investment Income
Income from trading activrties..
Related lo 0￿.¢¢ts of the charity
1,087
1,209
Total incoming re￿urCeS
133.593
156.311
Resources Expended:
Direct Charitable Expenditure
Fund Raising and Publscty
Management and Administration
54.507
7,924
98.369
56,545
11,390
99,763
Total resources expended
160,800
167,698
Net incoming resources
{27.2071
{11.3871
Balances at 31 March 2025
331.898
343.285
Balances at 31 March 2026
304.691
331,898

Solent Multiple Sclerosis Therapies Limited
Income and Expenditure Account
For the Period Ended 31 Mar¢h 2026
Mar-26
Mar-25
Total Income frMI continuing operat*)ns
133.593
156.311
Total expenditure from continuing op￿ationS
160,800
167,698
Net incomel{expenditure) for the year
27.20
11,387
There are no recognised gains or losses in 2026 or 2025 other than the net income forthe years.
The notes on pages 7 to 10 fomi part of these accounts

Solent Multiple Sclerosis Therapies Limited
Balance Sheet
As at 31 March 2026
Mar-26
May-25
Flxod A$$ets
Tangible Assets
202,931
209,416
Current Assets
Stocks
Prepayments
Cash al Bank and in Hanfl
3,945
120,738
124,683
3.261
146.591
149.852
Creditors: Amounts duè wlthin one year
Other creditors
10
3,835
8.282
Net Current Assets
120.848
141,570
Total Net Assets
323,779
350,986
Fund Balances
Income and Expenditure Account
304.691
331,898
Reserv￿ Caprtal
3,200
3,200
Operating Reserve Accwnt
15.888
15,888
Total Fund Balances
323.779
350,986
The Balan￿ Sheel continues on the fdlowrng page
The notes on pages 7 10 10 fomi part of these accounts

Solent Multiple Sclerosis Therapies Limited
Balance Sheet {continued
As at 31 March 2026
Dlre¢toYs' Statgment
The company is enlrtled to exernptvJn from audrt under Section 477 of the Compan￿$ Act 2006
rdaling lo small companies. lof the peric*l ended 31 Mareh 2026.
The members have not Tequired the company lo obtain an audit of its financial statements for the
perirxl ended 31 March 2026 in accordance with Seclvjn 476 of the Companies Act 2tIO6.
The dire¢lors acknohvledge th￿r resp0nsts1frt￿ for..
{a}
ensLEring thal the company keeps ￿Counting records v&hich complyth SectI￿s 386
and 387 of the Companies Act 21X* and
b}
preparing financial statements which give a true and fair view of the slate of affairs of the
cLympany as at the end of each financial year and of rts profft or loss for each financial
year In accordance with the requirements of Sect*)ns 394 and 395 and which otheThvise
cL¥npty wrth the requirements of the Companies ACE 20C6 relaling lo financial
statements. so fai as applicable lo the compar7y.
The accounts h8ve been prepared in accordance wth the special pro)risions of Part 15 of the
Companies Act 2006 Tela*ing lo small companies and with the Financial Reporting Standard
for Smaller Efttilies (effective Apfil 2008}.
These accounts were approved on..............
.. R Hafv- Director
.. L Rickman- DKe¢tor
The notes oll pages 7 to 10 foim part of these accounts

Solent Multiple S¢lerosis Therapies Limited
Notes to the Accounts
For the Pertod Ended 31 March 2026
ACCOUNTING POUCIES
8asis of Accounting
These acCo￿nts have been prepared on the basis of the histor￿1 cosl convention in
accordance wth the Financial ReportirFg Standard foi sMal￿r Enb"ties leffective April
20081 and wilh applicable Accounting Stsndards, the Accounting and Reports"ng by
Charrties- Statement of Recommended Pwtice {SORP 2005) and the Charities
Act 1993.
Incomlng Resources
Incoming resources are reported gross.
Legacles and Donatlons
Lega¢ies and donations are aC￿Unted for when the resources are receivable or when
the charivs enlittement is enforceable. Lega¢*s weived in the fomi of property
and investments are credrted at the k￿er of probate and market value. Other gifts in kind
are included in the accounts at market value. Assets for distribution are recognised onty
when distributed.. assets given for use by the charty are recognised when receivable"
stocks of unsold donated goods are not valued for balance sheet purposes.
Grants Receivable
Grants are fecognised when rece￿ab￿.
Dlre¢t Charitable Expenditure, Fund Raising. Management and Administratlon
Direct charitable expenditure c(MnprÉ5es a51 expenditure direct￿ relab"n9 to the objects of
the charty. When ne￿$sary, costs afe alk)cated be￿n dire¢t ¢haritable expenditLEre
fund-raising and management and ajmin1strat￿n on the basis of apportionment of the
relevant expenditure.
Lrfe Subscrfptlofis
There are no lrfe subscripttons
Commltments
Commf(ments made by the directo￿ that a￿ legalty binding have been accrued. Those
that are not ￿alty binding have not been charged in the accounts, but disdosed in
note11.
Tangible Fixed Assets and Deprxiatton
Tangible fixed assets are slated at cost.
Deprectalion is provided ovw the expected useful INes of each category of tangible frxed
asset as fotlows:
F(Jrniture and Office Equipment
25% on net bwk value
Plant and Equipment
25% on fiet b¢yJk valve
Buildings
Depreciated to reflect a valuation of £35000
Improvements lo Freehold Pioperty
2% on cost
The Compressw Chamber and ple￿v$ Improvements to Freehdd Property are fulty
depreciated.
Freehold Land has not been depreciated.

Solent Multiple Sclerosis Therapies Limited
Notes to the Accounts
For the Period Ended 31 March 2026
ACCOUNTING POUCIES I￿￿tinued)
Stocks
stocks aro valued at the of cost and net realtsable value after makirsg due
allowance for any obsolete or sb)w-moving rtems. Cost inclLides diiecl materials, labour
and overheads Inc￿rred tn Pfoviding each seNce. Net realisable value is bas￿1 on
esttmaled selling price less sdling costs.
Ca$h Flow Statement
The company has taken advantage of the exemption in the Financial Reporting Standard
1 from the fequirement lo disclose a Statement of Cash FEONS on the grounds that it 1$
a Sm￿1 company.
INVESTMENT INCOME
Mar-26
Mar-25
Bank Interest ReceivabEe
1,087
1.209
MANAGEMENT AND ADMINISTRATION
Mar-26
Mar-25
Central Management and Admmistrat
98.369
99.763
ANALYSIS OF TOTAL RESOURCES EXPENDED
Mar-26
Mar-25
Salaries
Utilit￿$
Supplies
DeprecialionlLoss on disposal
89.109
3.041
62,165
6.485
86.092
3.790
68.117
9,699
160.800
167.698
NET INCOMING RESOURCES
Mar-
Mar-25
This is slated after charging".
DeprecialionlLoss on disposal
6.485
9,699

Solent Multiple Sclerosis Therapies Limited
Notes to the Accounts
For the Period Ended 31 March 2026
INTEREST PAYABLE LESS RECEIVABLE
Mar46
Mar-25
Bank Interesl ReceNab
1.087
1,209
TAXATION
No corporation tax is payable as the company is a registered ¢harty.
TANGIBLE FIXED ASSETS
Imp's to
Freehokl
Propety
Com-
Plant
FurnilLFTè
FreelK)Id presS￿)n
and
and Office
Propety Chamber Equipment Equipment Total
Cost
Br<xJght Forward
Additions
Disposals
Carried Forvrdrd
254.222
39.884
22,244
62.076
6,576 385.002
254.222
39,884
22,244
62.076
6.576 385.002
Depreciation
Brought FoNord
Charge for the year
Eliminated on di5P'S
Cauied FOn￿ard
85,401
5.084
22,2*14
59.102
744
3.955 175.586
657
6,485
90.485
4.884 22,244
59,846
4,612 182,071
Net Book Value
At 31.03.26
163.737
35,(N)O
2.230
1.964 202,931
At 31.03.25
168.821
35.000
2,974
2,621 209,416
The Improvements to Freehokl Propety represent the costs incurred for the major
refurbishment of the Therapy Centre at Hewett Road, North End. Portsmouth.
The works were completed in 2008.
STOCK
Mar-26
Mar-25
Goods for resale

Solent Multiple S¢lerosis Therapies Limited
Notes to the Accounts
For the Period Ended 31 March 2026
10
CREDITORS." AMOUNTS DUE WITHIN ONE YEAR
Mar46
Mar-25
Taxation and s￿181 se¢urty
Accruals
Other creditors
1.354
2,309
172
3.835
1.779
3,667
2,836
8,282
11
LIMITED LIABIUTY
Every member of the eompany undertakes lo Contribute to the assets ofthe company,
in the event of the ¢￿￿panY being wound up. an amount not exceeding £1.
10

Solent Multiple Sclerosis Therapies Limited
Summary Income and Expenditure Account
For the Period Ended 31 March 2026
Mar-26
Mar-25
Income
133.593
156,311
133.593
156.311
Expenditure
Oxygen
Splints
Salaries
Building and Equipment Repairs and RenewaL8
11.445
9.519
89.109
9.324
3.041
12.900
6.032
606
14,056
5.877
1.925
86,092
12.860
3,790
12.367
4.512
537
20.410
6,612
1,300
General Office and Runniryj Costs
Insltrance Premiums
Diet Supplements,Vrtamins and G¢Jods for Resale
Piovision of Physio and T￿lap￿sts
Fund Raising Expenses
PTofessional Fees
HMRC Penatty
Depreciation
6.485
9,699
160.800
167.698
Net Surplusl(DefKitl for the Year
127,207)
{11.387
11

Solent Multiple Sclerosis Therapies Limited
Income Detail
For the Period Ended 31 March 2026
Mar-26
Mar-25
Bank interest
Book sales Iziffrti
Bonus ball
Collections
Community events
Corporate grants
Direct debil donatsons
EbayNintedlCharity Shop
EPOIAPSIM8sks
Gift aid
HDOT donation
Individijal donations
Inductions
Masons donkn.ons
Membership
National lottery grant
Office bottles
Physio donation
PortsmoLtth lottery
Reflex donations
Solar panel payThent
Sponsored events
Trust donations
1.087
1.209
364
1.256
354
21.025
7,474
1,626
19,442
590
90
7.133
483
1,720
21.256
I,(￿2
2,533
60,576
3.883
2,200
3.162
63.430
4,695
3.358
8.302
7.454
3,262
7,804
277
7,060
1,670
2.299
2.￿0
7,952
260
7.767
1.484
70
133.693
1S6.311
12

Solent Multiple Sclerosis Therapies Limited
Therapy Analysis
For the Period Ended 31 March 2026
Surplusl
{De￿it}
Donations
Costs
Physio
6,292
1,512
05teo
Refflex
4,495
2,565
14.864
10.787
4.077
13

Solent Multtple Sclerosis Therapies Limited
Bank Analysis
For the Period Ended 31 March 2026
Mar-26
Mar-25
Lloyds TSB
Current account
120.087
58,015
CAF Bank accounts
CAFCash account
Scottish Widows Bank
1.C69
Alr R9CgIvgr & Deluge Tank Fund
HDOT Chamber emergency
replacement reserve
87.215
Paypal
57
88
Total Bank Balances
120.144
146.387
Cash in hand
204
Total Bank and Cash
120,738
146,591
Balance per accounts
120,738
146,591
14

Solent Multiple Sclerosis Therapies Limited
Fixed Assets
For the Period Ended 31 March 2026
Imp's to
Pknt
Fymrture
Freehold Freehdd presS￿n
and
and Offi
Propety Property Chambw Equipmenl Equipment
Total
Cost
8rought Forward
Additions
Disposals
Carried FoThvard
254.222
39.884
22.244
62.076
6,576 385,002
254.222
39,884
22,244
62.076
6,576 385.002
Depreciation
Brought FO￿ard
Charge for the year
Eliminated on disp's
Carried FoThvard
85,401
5.084
4.884
22.244
59.102
744
3,955 175,586
657
6.485
90.485
4.884 22.244 59.846
4,612 182.071
Net Book Value
At 31.03.26
163,737
35.000
2.230
1,964 202.931
At 31.03.25
168,821
35.000
2.974
2,621 209.416
15

Solent Multiple Sclerosis Therapies Limited
Detailed In¢ome and Expenditure A¢count
For the Period Ended 31 March 2026
Mar-26
Mar-25
Income
133.593
156.311
133.593
156.311
Direct Costs
Fund Raising Costs
Promsion of Physio and Therapists
less contribution
Oxygen
less conlributton
Splints
EPO
P8yroll Costs
5,877
6.612
14,056
14.056
20.410
11,445
11.445
9.519
606
89.109
537
86.092
121.093
12.500
123,170
33,141
Gross SuTpIu$
Overheads
Building 3nd Equipment Repairs and Renth¥als
9.324
3,041
12.900
1.925
12.860
3.790
12,367
1,300
General Office and Running Costs
Professional Fees
HMRC Penalty
DepreciationlLoss on disposal
Insurance
6.485
6.032
9,699
4,512
39.707
44,528
Net SurplusllDeficitl for the year
27.207
11,387
Building and Equipment Repairs and Ren¢wals
Repairs and Maintenance
Buikling
Chamber
6.039
3.285
9,324
8,745
4,115
12,860
General Offica and Running Costs
Slaff Training
Miscellaneous
Telephone
Postsge and Stationery
Computer Costs
Subs¢riptsons
Bank charges
Cleaning and Hygiene
1,022
1.103
819
708
4,223
480
323
3,689
12,367
500
620
5,183
400
254
5,139
12.900
16